Immune responses triggering colitis and colitis-associated carcinoma

被引:0
作者
Rebecca Kesselring
Stefan Fichtner-Feigl
机构
[1] Laboratory of Chronic Immunopathology,Department of Surgery
[2] University Medical Center Regensburg,undefined
来源
Langenbeck's Archives of Surgery | 2012年 / 397卷
关键词
Colitis; Colitis-associated cancer; Immunology; Crohn's disease; Ulcerative colitis;
D O I
暂无
中图分类号
学科分类号
摘要
Inflammatory bowel diseases compromise of two forms of chronic intestinal inflammatory disorders: Crohn's disease and ulcerative colitis. Both forms of inflammatory bowel disease result from inappropriate inflammatory responses to the intestinal microbiota, but have different underlying immune responses. The connection between inflammation and cancer has long been established and longstanding inflammatory bowel diseases are an important risk factor for developing colorectal cancer. Colitis-associated colorectal cancer pathogenesis is highly influenced by specific inflammatory processes during inflammatory bowel disease. This article reviews the immunological responses affecting Crohn's disease and ulcerative colitis as well as the linkage of inflammatory bowel disease to the development of colitis-associated cancer. Finally, we discuss the prospects of using new research efforts to devise new immunotherapeutic approaches.
引用
收藏
页码:527 / 533
页数:6
相关论文
共 251 条
  • [1] Abraham C(2009)Inflammatory bowel disease N Engl J Med 361 2066-2078
  • [2] Cho JH(2011)Inflammatory bowel disease: beyond the boundaries of the bowel Expert Rev Gastroenterol Hepatol 5 401-410
  • [3] Actis GC(2010)Human and murine Th17 Curr Opin HIV AIDS 5 114-19
  • [4] Rosina F(2011)IKK- and NF-kappaB-mediated functions in carcinogenesis Curr Top Microbiol Immunol 349 159-169
  • [5] Mackay IR(2010)An innately dangerous balancing act: intestinal homeostasis, inflammation, and colitis-associated cancer J Exp Med 207 1573-1577
  • [6] Annunziato F(2005)IL-6 signaling promotes tumor growth in colorectal cancer Cell Cycle 4 217-220
  • [7] Cosmi L(2008)Regulatory T cells in inflammatory bowel disease Curr Opin Gastroenterol 24 733-741
  • [8] Romagnani S(2010)Targeting IL-23 and Th17-cytokines in inflammatory bowel diseases Curr Pharm Des 16 3656-3660
  • [9] Arkan MC(2010)Cancer and inflammation: promise for biologic therapy J Immunother 33 335-351
  • [10] Greten FR(2006)IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis Nat Med 12 99-106